Autophagy gene expression profiling identifies a defective microtubule-associated protein light chain 3A mutant in...

Area of Science:

• Cellular biology
• Molecular oncology
• Genetics

Background:

• Autophagy is a cellular stress response implicated in diseases like cancer and neurodegeneration.
• The precise role of autophagy in cancer is complex, with reported tumor-promoting and tumor-suppressive effects.
• Targeting autophagy for cancer therapy is challenging due to its multifaceted role.

Purpose of the Study:

• To systematically analyze gene expression data for 47 autophagy genes across various cancers.
• To identify common genetic alterations (deletions, amplifications, mutations) in autophagy genes.
• To understand the functional implications of these alterations in cancer development.

Main Methods:

• Systematic analysis of gene expression data for 47 autophagy genes.
• Examination of deletions, amplifications, and mutations in multiple cancer types.
• In vitro and in vivo studies to assess the functional impact of specific mutations.

Main Results:

• Frequent autophagy gene amplifications were observed in several cancer types.
• Prostate adenocarcinomas showed a higher frequency of autophagy gene deletions.
• Glioblastoma and thyroid carcinoma exhibited minimal alterations in autophagy genes.
• Individual autophagy core genes are infrequently altered, suggesting a requirement for functional autophagy in cancer cells.
• Hotspot mutations in MAP1LC3A's arginine-rich region were identified, reducing its cleavage by ATG4B.

Conclusions:

• Cancer cells generally require functional autophagy, as core genes are infrequently altered.
• Specific mutations, like those in MAP1LC3A, can impair autophagy function and potentially contribute to cancer development.
• Understanding autophagy gene alterations provides insights into cancer biology and potential therapeutic strategies.